Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome (Q46244096)

20 December 2017

title

Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome (English)

1 reference

20 December 2017

0 references

6

Jodi S Dashe

1 reference

20 December 2017

Donald D McIntire

5

object named as

Donald D McIntire

1 reference

20 December 2017

author name string

Allison E Jordan

1

1 reference

20 December 2017

Gregory L Jackson

2

1 reference

20 December 2017

Daralynn Deardorff

3

1 reference

20 December 2017

Geetha Shivakumar

4

1 reference

20 December 2017

publication date

1 October 2008

1 reference

20 December 2017

Journal of Maternal-Fetal and Neonatal Medicine

published in

1 reference

20 December 2017

volume

21

1 reference

20 December 2017

issue

10

1 reference

20 December 2017

page(s)

745-751

1 reference

20 December 2017

Perinatal depression: a systematic review of prevalence and incidence

cites work

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Delivery outcome after the use of antidepressants in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Birth weight in relation to morbidity and mortality among newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Prenatal depression effects on the fetus and newborn: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050802255488

10.1080/14767050802255488

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017